These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6799007)

  • 1. Evidence that extracellular cathepsin D is not responsible for the resorption of cartilage matrix in culture.
    Hembry RM; Knight CG; Dingle JT; Barrett AJ
    Biochim Biophys Acta; 1982 Feb; 714(2):307-12. PubMed ID: 6799007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
    Janusz MJ; Doherty NS
    J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The site of cartilage matrix degradation.
    Dingle JT; Dingle TT
    Biochem J; 1980 Aug; 190(2):431-8. PubMed ID: 7470058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The secretion of enzymes into the pericellular environment.
    Dingle JT
    Philos Trans R Soc Lond B Biol Sci; 1975 Jul; 271(912):315-24. PubMed ID: 239425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of lactoyl-pepstatin and the pepsin inhibitor peptide on pig cathepsin D.
    Kay J; Afting EG; Aoyagi T; Dunn BM
    Biochem J; 1982 Jun; 203(3):795-7. PubMed ID: 7115318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dinitrophenyl-pepstatins as active-site-directed localization reagents for cathepsin D.
    Matthews IT; Decker RS; Hornebeck W; Knight CG
    Biochem J; 1983 Apr; 211(1):139-47. PubMed ID: 6347185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin D. Characteristics of immunoinhibition and the confirmation of a role in cartilage breakdown.
    Dingle JT; Barrett AJ; Weston PD
    Biochem J; 1971 Jun; 123(1):1-13. PubMed ID: 4256870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activity of aspartic proteinase inhibitors related to pepstatin.
    Gunn JM; Owens RA; Liu WS; Glover GI
    Acta Biol Med Ger; 1981; 40(10-11):1547-53. PubMed ID: 6805191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and immunological studies of lysosomal and related proteinases in health and disease.
    Poole AR; Mort JS
    J Histochem Cytochem; 1981 Mar; 29(3A Suppl):494-502. PubMed ID: 7240722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin D activity in bovine articular cartilage, synovial membrane and fluid: degradation of cartilage proteoglycans from same joint.
    Bjelle A; Osterlin S
    J Rheumatol; 1976 Dec; 3(4):400-8. PubMed ID: 15110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin D: the lysosomal aspartic proteinase.
    Barrett AJ
    Ciba Found Symp; 1979; (75):37-50. PubMed ID: 399896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal cysteine endopeptidases mediate interleukin 1-stimulated cartilage proteoglycan degradation.
    Buttle DJ; Saklatvala J
    Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):657-61. PubMed ID: 1445226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteoglycan-degrading enzymes. A radiochemical assay method and the detection of a new enzyme cathepsin F.
    Dingle JT; Blow AM; Barrett AJ; Martin PE
    Biochem J; 1977 Dec; 167(3):775-85. PubMed ID: 23763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of cathepsin inhibitors on rat embryonic development in vitro. Evidence that cathepsin D is unimportant in the proteolytic function of yolk sac.
    Freeman SJ; Brown NA
    J Embryol Exp Morphol; 1985 Apr; 86():271-81. PubMed ID: 4031744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.
    Briozzo P; Morisset M; Capony F; Rougeot C; Rochefort H
    Cancer Res; 1988 Jul; 48(13):3688-92. PubMed ID: 3378211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A serine proteinase inactivator inhibits chondrocyte-mediated cartilage proteoglycan breakdown occurring in response to proinflammatory cytokines.
    Bryson H; Bunning RA; Feltell R; Kam CM; Kerrigan J; Powers JC; Buttle DJ
    Arch Biochem Biophys; 1998 Jul; 355(1):15-25. PubMed ID: 9647662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic enzymes in human cartilage: the pathogenesis of osteoarthritis.
    Sapolsky A; Howell D
    Compr Ther; 1976 Oct; 2(10):33-40. PubMed ID: 975757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic assessment of cathepsin D in osteoarthritic cartilage.
    Vittorio N; Crissman JD; Hopson CN; Herman JH
    Clin Exp Rheumatol; 1986; 4(3):221-30. PubMed ID: 3769240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The action of cathepsin D in human articular cartilage on proteoglycans.
    Sapolsky AI; Altman RD; Woessner JF; Howell DS
    J Clin Invest; 1973 Mar; 52(3):624-33. PubMed ID: 4265383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of dinitrophenyl-pepstatins with human cathepsin D and with anti-dinitrophenyl antibody. Development of potential reagents for the localization in vivo of active proteinases at sites of tissue injury.
    Knight CG; Hornebeck W; Matthews IT; Hembry RM; Dingle JT
    Biochem J; 1980 Dec; 191(3):835-43. PubMed ID: 6793037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.